Radiation therapy/ Radiation Oncology – Pehr Lind's research group

We focus on clinical radiation therapy in breast, prostate and rectal cancer. We study organ sparing, curative (chemo-) radiotherapy in early rectal cancer and the broad introduction of artificial intelligence (AI) from scan to plan and thoroughout the delivery of radiotherapy, plus functional MR and photon-counting CT. Most trials are done in collaboration with other national and international academic centres and business vendors. Assoc Prof A Siegbahn is deputy leader.

Publications

All publications from group members

Journal article: ACTA ONCOLOGICA. 2026;65:543-552
Evaluation of 3D-CRT vs. VMAT for radiotherapy of whole breast with simultaneous integrated boost
Johansson G; Kojoj R; Surdashi S; Olin M; Freden E; Sen P; Dahl E; Wendt C
Journal article: JOURNAL OF RADIOTHERAPY IN PRACTICE. 2026;25:e9
Qualitative and quantitative evaluation of auto-segmented clinical target volumes and organs at risk in radiotherapy of rectal cancer
Dahlstedt-Hassler L; Siegbahn A; Kojoj R; Schedin A; Lagerback C; Lind P
Journal article: RADIOTHERAPY AND ONCOLOGY. 2025;206:s1170-s1173
1489 STAR-TREC (NCT02945566): A randomised phase II/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early/intermediate risk rectal cancer
Marijnen CAM; Sebag-Montefiore D; Homer V; Gates S; Al-Najami I; Angenete E; Appelt A; Baatrup G; Beets G; Burger JWA; Spindler K-LG; Geh I; Gilbert A; Haustermans K; Holman F; Korsgen S; Lind P; Martling A; Peters F; Teo M; West N; Wolthuis A; de Wilt JWH; ESTRO SPBSCLG
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2025;206:S1170-S1173
STAR-TREC (NCT02945566): A randomised phase II/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early/intermediate risk rectal cancer
Marijnen CAM; Sebag-Montefiore D; Homer V; Gates S; Al-Najami I; Angenete E; Appelt A; Baatrup G; Beets G; Burger JWA; Spindler K-LG; Geh I; Gilbert A; Haustermans K; Holman F; Korsgen S; Lind P; Martling A; Peters F; Teo M; West N; Wolthuis A; de Wilt JWH; Bach SP
Article: JOURNAL OF CLINICAL ONCOLOGY. 2025;43(10):1240-1253
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Palmer DH; Jackson R; Springfeld C; Ghaneh P; Rawcliffe C; Halloran CM; Faluyi O; Cunningham D; Wadsley J; Darby S; Meyer T; Gillmore R; Lind P; Glimelius B; Falk S; Ma YT; Middleton GW; Cummins S; Ross PJ; Wasan H; Mcdonald A; Crosby T; Hammel P; Borg D; Sothi S; Valle JW; Mehrabi A; Bailey P; Tjaden C; Michalski C; Hackert T; Buechler MW; Neoptolemos JP
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16_suppl):e15615
Bowel bag sparing in palliative radiotherapy (pRT) of rectal cancer (rCa): Tradeoff between organs at risk (OARs) and use of AI to reduce radiation oncologist (RO) workload.
Fredén E; Knutsson J; Yousif R; Siegbahn A; Lind PA
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16)
Bowel bag sparing in palliative radiotherapy (pRT) of rectal cancer (rCa): Tradeoff between organs at risk (OARs) and use of AI to reduce radiation oncologist (RO) workload
Freden E; Knutsson J; Yousif R; Siegbahn A; Lind PA
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2024;194:S1491-S1493
Delineation variations in RT planning of rectum cancer patients using the Swedish guideline
Freden E; Knutsson J; Lagerback C; Siegbahn A; Lind P
Journal article: RADIOTHERAPY AND ONCOLOGY. 2024;194:s1491-s1493
723: Delineation variations in RT planning of rectum cancer patients using the Swedish guideline
Fredén E; Knutsson J; Lagerbäck C; Siegbahn A; Lind P
Article: JOURNAL OF SURGICAL ONCOLOGY. 2024;129(4):734-744
The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial
Caspers IA; Slagter AE; Lind P; Sikorska K; Wiklund K; Ponten F; Nordsmark M; van de Velde CJH; Kranenbarg EM-K; van Sandick JW; Jansen EPM; van Laarhoven HWM; Verheij M; van Grieken NCT; Cats A
Doctoral thesis: 2024
Radiation-induced toxicity and secondary malignant neoplasms in radiotherapy of intrathoracic tumors
Lideståhl A
Article: GASTRIC CANCER. 2024;27(1):102-109
Effect of preoperative chemotherapy on the histopathological classification of gastric cancer
Caspers IA; Biesma HD; Wiklund K; Ponten F; Lind P; Nordsmark M; Sikorska K; Meershoek-KleinKranenbarg E; Hartgrink HH; van de Velde CJH; van Sandick JW; Verheij M; Cats A; van Grieken NCT
Article: CANCERS. 2023;15(24):5736
Dosimetric Comparison of Conventional Radiotherapy, Volumetric Modulated Arc Therapy, and Proton Beam Therapy for Palliation of Thoracic Spine Metastases Secondary to Breast or Prostate Cancer
Lidestahl A; Freden E; Siegbahn A; Johansson G; Lind PA; Ishikawa E; Matschke J; Rueckert M; Deloch L
Journal article: JOURNAL OF RADIOTHERAPY IN PRACTICE. 2022;21(4):455-461
Changes on myocardial perfusion scintigraphy and contrast-enhanced cardiac magnetic resonance imaging after definitive radiotherapy in patients with lung cancer
Lidestahl A; Larsson T; Thoren L; Brodin O; Lind PA
Article: MEDICAL PHYSICS. 2022;49(8):5589-5603
Modeling secondary cancer risk ratios for proton versus carbon ion beam therapy: A comparative study based on the local effect model
Hufnagl A; Johansson G; Siegbahn A; Durante M; Friedrich T; Scholz M
Article: CANCERS. 2022;14(12):2963
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
Slagter AE; Caspers IA; van Grieken NCT; Walraven I; Lind P; Meershoek-Klein Kranenbarg E; Grootscholten C; Nordsmark M; van Sandick JW; Sikorska K; van de Velde CJH; Jansen EPM; Verheij M; van Laarhoven HWM; Cats A
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2022;170:S1255-S1256
Heart dose variability in RT of left breast cancer patients treated in deep inspiration breath hold
Johansson G; Freden E; Knutsson J; Olin M; Dagertun L; Siegbahn A
Journal article: RADIOTHERAPY AND ONCOLOGY. 2022;170:s1255-s1256
PO-1480 Heart dose variability in RT of left breast cancer patients treated in deep inspiration breath hold
Johansson G; Fredén E; Knutsson J; Olin M; Dagertun L; Siegbahn A
Review: ACTA ONCOLOGICA. 2022;61(4):523-530
Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives
Merk C; Martling A; Lindberg J; Benhaim L; Taieb J; Lind P
Article: GASTRIC CANCER. 2022;25(2):401-410
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial
Slagter AE; Vollebergh MA; Caspers IA; van Sandick JW; Sikorska K; Lind P; Nordsmark M; Putter H; Braak JPBM; Kranenbarg EM-K; van de Velde CJH; Jansen EPM; Cats A; van Laarhoven HWM; van Grieken NCT; Verheij M
Show more

Staff and contact

Group leader

All members of the group

Other people connected to the group

Agudelo-Guerra, Victoria

Dahlstedt, Love

Hasslow, Johan

Johansson, Gracinda

Kojoj, Rafat

Lagerbäck, Cecilia

Nilsson, Jonna

Rosen, Alice

Schedin, Anna

Viktor, Winther

Winemar, Maria

Visiting address

Department of Oncology, Sodersjukhuset, Sjukhusbacken 10, Stockholm, 11883, Sverige

Postal address

Department of Oncology, Sodersjukhuset, Sjukhusbacken 10, Stockholm, 11883, Sverige